Mother, infant, and syphilis: increasing cause for concern in British Columbia

In 1997 national goals were set for maintaining infectious syphilis rates below 0.5 per 100000 population and preventing all endemic congenital syphilis cases. Such optimism proved unfounded; that same year infectious syphilis rates began to rise in BC, to 7.7 cases per 100000 in 2006. Most recently, this epidemic has led to an increased number of congenital syphilis cases and syphilis infections in pregnant women, similar to recent reports from Alberta.

Epidemiology
From 2003 to 2006, nine to eleven pregnant women were diagnosed with infectious syphilis annually (70% of these infections were identified through prenatal syphilis screening). Since 2005 there have been seven cases of early congenital syphilis, an increase compared with the fourre­ported cases during the previous decade. 

In reviewing these seven re­cent cases, five mothers had histories of substance use or street involvement with delayed or no prenatal care. Of the two remaining mothers with appropriate prenatal care, one woman was not screened prenatally for syphilis. Four of the seven infants were stillborn or died after birth.

Clinical presentation
The clinical diagnosis of infectious syphilis in pregnancy can be difficult. The chancre associated with primary syphilis may not be readily apparent, or may be misdiagnosed as another ulcerative disorder (e.g., herpes). Women with secondary syphilis may have nonspecific symptoms (including rash, fever, malaise, and lympha­denopathy), and women at any stage of infection can be asymptomatic.  

Infants are typically infected in utero, although transmission can occur through contact with active genital lesions at delivery. The risk of transmission from mother to child depends largely on the duration of the disease in the mother (70% to 100% transmission with primary or second­ary, 40% with early latent, and 10% with late latent syphilis), with fetal death occurring in about 40% of pregnancies. Treatment of mothers using the stage-appropriate doses of benzathine penicillin G will reduce the risk of transmission. 

Two-thirds of infants with early congenital syphilis (onset less than 2 years of age) may be asymptomatic. Signs include snuffles or nasal discharge, hepatosplenomegaly, distended abdomen, and desquamative skin rashes. Other signs suggestive of congenital syphilis include infants found to have hemolytic anemia or radio­graphic abnormalities of the long bones.

Implications for practice
Currently 90% of specimens collected for prenatal blood screening in BC include testing for syphilis. All pregnant women should be offered screening for syphilis in the first trimester as universal prenatal syphilis screening remains the cornerstone for detection and treatment, and prevention of vertical transmission. Improving access to prenatal care including syphilis testing for marginalized women at higher risk of syphilis infection is particularly important.  

Screening should be repeated at 28 to 32 weeks’ gestation in women at high risk of acquiring syphilis (i.e.,  women who have had sexual contact of a syphilis case, sex-trade workers, street-involved or homeless women, users of injection drugs, women with multiple sexual partners, women with a previous history of syphilis, HIV, or other STI, or women with a sexual partner from a syphilis-endemic country). However, infections may occur in women without risk factors following an initial negative syphilis prenatal screen. 

Testing should be performed at any stage of pregnancy if clinically indicated (particularly if genital ulcers are present), and for any woman delivering a stillborn infant at ≥20 weeks gestation. Screening for HIV and other STI is recommended for any women with a positive syphilis result. 

Any infants presenting with signs or symptoms compatible with early congenital syphilis should be tested. Asymptomatic infants should be screened at birth if their mother was not tested for syphilis prenatally, had a reactive prenatal syphilis test, or was at high risk for infection in pregnancy after a negative prenatal syphilis test.

Management 
The management of infectious syphilis in pregnancy and congenital syphilis is complex and requires specialist care. STI Clinic staff at the BC Centre for Disease Control follow up on all positive syphilis test results and are available by telephone at 604 660-6161 to answer questions regarding the interpretation of syphilis serology results and further management of in­fectious syphilis cases in pregnancy.

—Mark Gilbert, MD, FRCPC
—Linda Knowles, BScN
—Faye Neuman, BSN
—Melanie Achen, BSN
—Hugh Jones, MD, Dip Ven
—Gina Ogilvie, MD, MSc
—Michael Rekart, MD, DTM&H
STI/HIV Prevention and Control, BC Centre for Disease Control

Further reading:

Singh A, Sutherland K, Lee B, Robinson JL, et al. Resurgence of early congenital syphilis in Alberta. CMAJ 2007;177:33-36.

Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections 2006 Edition. Syphilis [updated Oct 2007]. www.phac-aspc.gc.ca/std-mts/sti_2006/sti_intro2006_e.html (accessed 20 December 2007).

BC Centre for Disease Control British Columbia Treatment Guidelines: Sexually Transmitted Infections in Adolescents and Adults 2007. www.bccdc.org/division.php?item=3#Reports (accessed 20 December 2007).

Mark Gilbert, MD, MHSc, FRCPC, Linda Knowles, BScN, Faye Neuman, BSN,, Melanie Achen, BSN,, Hugh Jones, MD, Gina Ogilvie, MD, MSc, FCFP, DrPH, Michael L. Rekart, MD, DTM&H, MHSc. Mother, infant, and syphilis: increasing cause for concern in British Columbia. BCMJ, Vol. 50, No. 1, January, February, 2008, Page(s) 17 - BC Centre for Disease Control.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply